Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma thrombin-activatable fibrinolysis inhibitor levels and Thr325Ile polymorphism as a risk marker of myocardial infarction in Egyptian patients.

Acta cardiologica - 1 Aug 2011

Kamal Hanan M, Ahmed Amal S, Fawzy Manal S, Mohamed Faten A, Elbaz Amani A

Abstract excerpt

OBJECTIVE: The objective of this study was to investigate whether thrombin activatable fibrinolytic inhibitor (TAFI) Thr325Ile polymorphism and TAFI antigen (Ag) levels could constitute a risk marker of myocardial infarction (MI) in Egyptian patients. STUDY POPULATION AND RESULTS: The study included forty-six patients with acute MI (mean age 55.7 +/- 8.1 years, 33 men, 13 women) compared with age and sex-matched...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Carboxypeptidase B2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Myocardial Infarction

Share to Polymorphism, Single Nucleotide

Share to Risk Assessment

Source

Identifiers

PMID: 21894805
DOI: 10.1080/ac.66.4.2126597

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma thrombin-activatable fibrinolysis inhibitor levels and Thr325Ile polymorphism as a risk marker of myocardial infarction in Egyptian patients.PMID 21894805Read ↗

Thrombin-activatable fibrinolysis inhibitor genetic polymorphisms as markers of the type of acute coronary syndrome.Semantic proximity Read ↗

Association of genetic variants of hemostatic genes with myocardial infarction in Egyptian patients.Semantic proximity Read ↗

Genetic variations in the thrombin-activatable fibrinolysis inhibitor gene and risk of cardiovascular disease: a systematic review and meta-analysis.Semantic proximity Read ↗

Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system.Semantic proximity Read ↗

Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe.Semantic proximity Read ↗

Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Plasma Levels and Thr325Ile Genetic Polymorphism in a Cohort of Egyptian Sickle Cell Disease Patients and Impact on Disease SeveritySemantic proximity Read ↗

[Prognosis value of thrombin activatable fibrinolysis inhibitor concentration and C1040T polymorphism in acute myocardial infarction treated with fibrinolysis].Semantic proximity Read ↗

Association of rs2781666 G/T polymorphism of arginase I gene with myocardial infarction in Tunisian male population.Semantic proximity Read ↗

Seven functional polymorphisms in the CETP gene and myocardial infarction risk: a meta-analysis and meta-regression.Semantic proximity Read ↗

Thrombin activatable fibrinolysis inhibitor plasma levels and TAFI Thr325Ile genetic polymorphism in a cohort of Egyptian sickle cell disease patients and impact on disease severity.Semantic proximity Read ↗

Association of Hemostatic Gene Polymorphisms With Early-Onset Ischemic Heart Disease in Egyptian Patients.Semantic proximity Read ↗

Genetic Polymorphisms Associated with Thrombotic Disease Comparison of Two Territories: Myocardial Infarction and Ischemic Stroke.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.